Introduction of oxygen vacancy to Bi2Mn4O10 supported by nickel foam for 1O2 dominated metronidazole degradation under dielectric barrier discharge plasma

Shen, Tianyao; Wang, Xiaojing; Li, Jiaqin; Xu, Peng; Yang, Chunyan; Wang, Peng; Zhang, Guangshan

doi:10.1016/j.apcatb.2023.122518

Cited by 26 publications

(1 citation statement)

References 87 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A completely different approach was proposed by Shen et al, who used a ceramic catalyst to enhance the degradation of a nitroimidazole antibiotic in a dielectric barrier discharge. The catalyst acted as a source of oxygen vacancies and helped to create additional reactive oxygen species and thereby enhance the antibiotic destruction in the plasma discharge [146]. Earlier studies [147] also reported effective degradation of ofloxacin and ciprofloxacin, with structural changes attributed to the hydroxyl radical and ozone, but further analyses revealed that ciprofloxacin degradants exhibited higher antimicrobial activity post-plasma treatment, revealing that biological activity can be retained in the degradants.…”

Section: Discussionmentioning

confidence: 97%

Recent Developments in the Use of Plasma in Medical Applications

O’Neill,

Bourke

2024

Plasma

View full text Add to dashboard Cite

A detailed review of the scientific literature was undertaken to examine the most recent developments in plasma processing in the field of medicine. The first part of the review includes a detailed breakdown of the different types of coatings that can be applied onto medical devices using plasma, with a specific focus on antimicrobial surfaces. The developments in plasma-deposited biocompatibles, drug delivery and adhesive coatings in 2023 are described, and specific applications in additive manufacturing are highlighted. The use of plasma and plasma-activated liquids as standalone therapeutics continues to evolve, and pertinent advances in this field are described. In addition, the combination of plasma medicine with conventional pharmaceutical interventions is reviewed, and key emerging trends are highlighted, including the use of plasma to enhance drug delivery directly into tissue. The potential synergies between plasma medicine and chemotherapeutics for oncology and infection treatment are a growing area, and recent advancements are noted. Finally, the use of plasma to control excess antibiotics and to intentionally degrade such materials in waste streams is described.

show abstract

Section: Discussionmentioning

confidence: 97%